- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01076673
Effect of Autologous Peripheral Blood Stem Cell Treatment on Articular Cartilage Regeneration
March 12, 2015 updated by: Dr. Khay-Yong Saw, Kuala Lumpur Sports Medicine Centre
Articular Cartilage Regeneration With Autologous Peripheral Blood Stem Cells Versus Hyaluronic Acid: A Randomized, Controlled Trial
The purpose of this study was to compare histologic and MRI evaluation of articular cartilage regeneration in patients with chondral lesions treated by arthroscopic subchondral drilling followed by postoperative intra-articular injections of hyaluronic acid (HA) with and without peripheral blood stem cells (PBSC)
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study was to compare histologic and magnetic resonance imaging (MRI) evaluation of articular cartilage regeneration in patients with chondral lesions treated by arthroscopic subchondral drilling followed by postoperative intra-articular injections of hyaluronic acid (HA) with and without peripheral blood stem cells (PBSC)
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kuala Lumpur, Malaysia
- Kuala Lumpur Sports Medicine Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who have signed informed consent form
- Patients with only unilateral isolated or multiple knee articular cartilage lesions demonstrated MRI scanning, with up to one previous operation on that knee
- Patients who are either male or female aged between 18 to 50 years old, corresponding to availability of normative International Knee Documentation Committee (IKDC) data.
- Female patients of childbearing age must have negative pregnancy tests and are advised to take contraceptive precautions throughout the study.
Exclusion Criteria:
- Patients with bilateral knee lesions
- Patients with the presence of ligamentous injury which would require reconstruction, varus or valgus deformity greater than 10 degrees, previous open total menisectomy requiring osteotomy, and cases that require complex surgery prior to cartilage regeneration
- Patients with significant cognitive impairment, non-ambulatory status or lower extremities amputation other than toes, serious illness or medication affecting operative risk or wound healing (e.g. steroid intake, anticoagulation), and poorly controlled diabetes mellitus with a baseline HbA1c more than 8
- Patients with significant peripheral vascular disease as indicated by absent dorsalis pedis or posterior tibial pulses.
- Patients who cannot read English will be excluded from the study as they will be unable to complete the study questionnaires in an objective manner
- Female patients who are pregnant
- Patients with any contradictions to MRI scanning
- Patients with body mass index (BMI) of over 35
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: PBSC and Hyaluronic Acid
Peripheral blood stem cells and hyaluronic acid injections
|
Peripheral blood stem cells and hyaluronic acid injections
Other Names:
|
ACTIVE_COMPARATOR: Hyaluronic Acid
|
Hyaluronic acid injections
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in tissue histology after subchondral drilling surgery using serial MRI scanning and cartilage biopsies
Time Frame: 18 months
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improved long term functional outcome of subchondral drilling surgery in the knee joint
Time Frame: 18 months
|
18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Khay-Yong Saw, Dr., Kuala Lumpur Sports Medicine Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (ACTUAL)
May 1, 2012
Study Completion (ACTUAL)
May 1, 2012
Study Registration Dates
First Submitted
February 24, 2010
First Submitted That Met QC Criteria
February 25, 2010
First Posted (ESTIMATE)
February 26, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
March 17, 2015
Last Update Submitted That Met QC Criteria
March 12, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KLSMC-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Articular Cartilage Disorder of Knee
-
Sewon Cellontech Co., Ltd.UnknownDefect of Articular Cartilage | Articular Cartilage Disorder of Knee | Degeneration; Articular Cartilage, KneeKorea, Republic of
-
Middle East Technical UniversityCompletedOsteoarthritis | Degenerative Lesion of Articular Cartilage of Knee | Articular Cartilage Disorder of KneeTurkey
-
KLSMC Stem Cells, Inc.CompletedArticular Cartilage Disorder of Knee | Articular Cartilage; DegenerationUnited States, Malaysia
-
BioGend Therapeutics Co.LtdRecruitingArticular Cartilage Disorder of KneeTaiwan
-
University Hospital, Strasbourg, FranceWithdrawn
-
Christopher KaedingSmith & Nephew, Inc.TerminatedArticular Cartilage Disorder of KneeUnited States
-
Episurf Medical Inc.MCRARecruitingDegenerative Lesion of Articular Cartilage of KneeUnited States, Canada, Germany, United Kingdom
-
Ettore Sansavini Health Science FoundationCompletedDegenerative Lesion of Articular Cartilage of KneeItaly
-
CellCoTec B.V.CompletedArticular Cartilage Lesion of the KneeBelgium, Poland, United Kingdom
-
Oligo Medic Pty LtdMobius Medical Pty Ltd.RecruitingChondral Defect | Articular Cartilage Disorder of Knee | Articular Cartilage DefectAustralia, Canada
Clinical Trials on Peripheral blood stem cells and hyaluronic acid injections
-
KLSMC Stem Cells, Inc.CompletedArticular Cartilage Disorder of Knee | Articular Cartilage; DegenerationUnited States, Malaysia
-
Meshalkin Research Institute of Pathology of CirculationUnknownHeart Failure | Acute Myocardial InfarctionRussian Federation
-
RibozyomeCompletedHIV Infections | Lymphoma, Non-HodgkinUnited States
-
South China Research Center for Stem Cell and Regenerative...UnknownSenescence Wrinkles, Acne, Pitting Scar
-
DKMS gemeinnützige GmbHActive, not recruiting
-
Meshalkin Research Institute of Pathology of CirculationCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedKidney CancerUnited States
-
Clinica Universidad de Navarra, Universidad de...Completed
-
Nearmedic Plus LLCInstitute of Plastic Surgery and Cosmetology, Moscow, RussiaCompletedSkin AgingRussian Federation
-
South China Research Center for Stem Cell and Regenerative...UnknownCartilage Damage | Degenerative Osteoarthritis